Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR) Trial

NCT07567027 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT07567027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07567027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR) Trial
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Recruiting
Start date
June 17, 2026
Completion date
June 1, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer (diagnosis), transperineal cryoablation